Clinical Cancer Research

RTFCCR and Anticancer Fund Launch Ingenious, a Joint Call to Support Innovative Treatment Strategies to Improve Cancer Survival

News, Clinical Cancer Research, Success Story / By

RTFCCR and Anticancer Fund Launch Ingenious, a Joint Call to Support Innovative Treatment Strategies to Improve Cancer Survival  May 8, 2026 The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and the Anticancer Fund (ACF) have launched Ingenious, a new joint Call for Research Projects (CfRP) aimed at supporting academic‑led clinical trials evaluating whether treatment strategies that incorporate predictive information can improve patient […]

RTFCCR and Anticancer Fund Launch Ingenious, a Joint Call to Support Innovative Treatment Strategies to Improve Cancer Survival Read More »

Amplifying Patient Voice: Success Story

News, Clinical Cancer Research, Success Story / By

Amplifying Patient Voice: Success Story March 27, 2026 Showcasing Outstanding Patient Partnership in the HYPERION CCA Study  We are delighted to spotlight the partnership between HYPERION CCA research team, and the Cholangiocarcinoma Foundation (CCF). ​The HYPERION CCA study is led by Dr. Eugene Koay at The University of Texas MD Anderson Cancer Center, one of our grantees.​   This research team

Amplifying Patient Voice: Success Story Read More »

Grantee Spotlight: Developing New ImmuneBased Treatments for Aggressive Brain Cancer

News, Clinical Cancer Research, Success Story / By

Grantee Spotlight: Developing New Immune-Based Treatments for Aggressive Brain Cancer March 24, 2026 The Challenge Malignant brain tumors, such as glioblastoma, are among the most aggressive cancers in adults. Despite maximal standard therapy – surgery followed by radiotherapy and temozolomide chemotherapy – most patients live only about 15 to 16 months after diagnosis. For decades, progress has been slow, and new treatment approaches are

Grantee Spotlight: Developing New ImmuneBased Treatments for Aggressive Brain Cancer Read More »

Rising Tide Webinar Series Highlights Success Stories of Patient Partnership in Clinical Research

News, Clinical Cancer Research / By

Rising Tide Webinar Series Highlights Success Stories of Patient Partnership in Clinical Research February 27, 2026 The Partnering with Patients to Improve Clinical Trials webinar series, developed by the Rising Tide Foundation for Clinical Cancer Research in collaboration with the LUNGevity Foundation, recently released two new episodes showcasing impactful models of patient partner involvement across

Rising Tide Webinar Series Highlights Success Stories of Patient Partnership in Clinical Research Read More »

World Cancer Day – Empowering Meaningful Patient Involvement at Scale

News, Clinical Cancer Research / By

World Cancer Day – Empowering Meaningful Patient Involvement at Scale February 4, 2026 Celebrating World Cancer Day, the Rising Tide Foundation for Clinical Cancer Research is proud to support EUPATI in developing an online training platform designed to equip professionals with the skills needed to embed meaningful patient involvement in clinical development. EUPATI, the European

World Cancer Day – Empowering Meaningful Patient Involvement at Scale Read More »

Grantee Spotlight: The POSITIVE Clinical Trial – Addressing Fertility After Breast Cancer

News, Clinical Cancer Research / By

Grantee Spotlight: The POSITIVE Clinical Trial – Addressing Fertility After Breast Cancer January 22, 2026 A Critical Gap Each year, approximately 2.3 million women are diagnosed with breast cancer, and about 30% of them are premenopausal. Despite this significant proportion, premenopausal women have long been underrepresented in research – particularly when it comes to endocrine

Grantee Spotlight: The POSITIVE Clinical Trial – Addressing Fertility After Breast Cancer Read More »

RTFCCR and LUNGevity Launch New Research Funding Opportunity to Tackle Lung Cancer Recurrence and Treatment Resistance

News, Clinical Cancer Research / By

RTFCCR and LUNGevity Launch New Research Funding Opportunity to Tackle Lung Cancer Recurrence and Treatment Resistance  January 20, 2026 The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and the LUNGevity Foundation have announced a new joint Request for Applications (RFA) to accelerate clinical innovations in lung cancer by supporting interventional trials that address two

RTFCCR and LUNGevity Launch New Research Funding Opportunity to Tackle Lung Cancer Recurrence and Treatment Resistance Read More »

RTFCCR and KFS Co-Fund Three Innovative Clinical Trials in Switzerland

News, Clinical Cancer Research / By

RTFCCR and KFS Co-Fund Three Innovative Clinical Trials in Switzerland  December 15, 2025 The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and Krebsforschung Schweiz (KFS) are proud to announce the co-funding of three Swiss clinical trials aimed at improving patient outcomes and advancing cancer research. Improving Quality of Life in Metastatic Prostate Cancer Led

RTFCCR and KFS Co-Fund Three Innovative Clinical Trials in Switzerland Read More »

Rising Tide Foundation for Clinical Cancer Research at ESMO AI & Digital Oncology 2025: Driving Innovation in Cancer Research

News, Clinical Cancer Research / By

Rising Tide Foundation for Clinical Cancer Research at ESMO AI & Digital Oncology 2025: Driving Innovation in Cancer Research November 21, 2025 Berlin, November 12-14th – The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) proudly joined the inaugural ESMO AI and Digital Oncology conference in Berlin, a groundbreaking event that brought together leading experts, researchers, and innovators to explore the transformative

Rising Tide Foundation for Clinical Cancer Research at ESMO AI & Digital Oncology 2025: Driving Innovation in Cancer Research Read More »

Scroll to Top